News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
492
Sources here
19
Companies here
17
Search results Stored financial headlines

Active search

492 matching headlines

Ticker or company: PFMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Pfizer and Valneva’s Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Submission based on favorable efficacy and safety results from Phase 3 VALOR trial NEW YORK & LYON, France, August 14, 2026--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the European Medicines Agency (EMA) has validated the …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company +1 more
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OppFi chief executive Todd Schwartz buys $427,680 in company stock

OppFi CEO Todd G. Schwartz purchased 60,000 shares of the company's Class A Common Stock for $427,680, following a 24% stock decline over the past week. This insider buying comes after the company reported disappointing Q2 financial results, missing analyst expectations for earnings and …

OPFI main company
Sharemaestro market context Trend signal ended 52 weeks -26.8% OPFI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OppFi (OPFI) CEO Todd Schwartz adds 60,000 shares at $7.13 weighted price

OppFi CEO Todd G. Schwartz, a greater-than-10% owner, purchased 60,000 shares of Class A common stock on August 13, 2026, at a weighted average price of $7.128 per share through the TGS Revocable Trust. This transaction increased the trust's indirect holdings to 553,733 shares, …

OPFI main company
Sharemaestro market context Trend signal ended 52 weeks -26.8% OPFI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Maurice Duca (APPF) details 6.41M-share AppFolio stake and 44.7% voting power

Maurice J. Duca has filed an amended Schedule 13D, reporting a beneficial ownership of 6,410,682 Class A Shares in AppFolio, Inc., which represents 21.2% of the outstanding Class A shares as of August 13, 2026. His total holdings, including Class B shares, account for …

APPF main company
Sharemaestro market context Price above Trend Line 52 weeks -25.8% APPF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Hovnanian Enterprises (HOV) Projected to Release Earnings on Thursday

Hovnanian Enterprises (HOV) is slated to release its Q3 2026 earnings before market open on Thursday, August 20th, with analysts forecasting a loss of $0.56 per share on revenue of $723.5 million. The company's previous quarter surpassed expectations, reporting negative $0.46 EPS against an …

HOVNP main company
Sharemaestro market context Price below Trend Line 52 weeks +6.9% HOVNP stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TechnipFMC plc (FTI) Stock Forecasts

Argus has raised its target price for TechnipFMC (FTI) to $83.00, an increase from its previous target. The report highlights TechnipFMC as the largest provider of offshore oilfield services, specializing in integrated deep-water offshore oil and gas development solutions. This includes subsea equipment and …

FTI main company
Sharemaestro market context Trend signal active 52 weeks +118.2% · Next-week setup positive 57.9% FTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AppFolio General Counsel Evan Pickering Sells 727 Shares

Key Points The disposition involved 727 shares with a total transaction value of ~$146,000. The activity reduced the executive's direct equity position by 12%. Disclosed activity consisted of 264 shares withheld for tax obligations and 463 shares sold under a Rule 10b5-1 trading plan. …

APPF main company
Sharemaestro market context Price above Trend Line 52 weeks -25.8% APPF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

How Pfizer’s Higher 2026 Guidance And LITFULO Trial Results At Pfizer (PFE) Have Changed Its Investment Story

In early August 2026, Pfizer Inc. reported second-quarter results showing revenue of US$15,034 million and a net loss of US$248 million, alongside US$4.30 billion in non-cash intangible asset impairments and a modest increase in full-year 2026 revenue guidance to US$60.50–US$62.50 billion. A key offsetting …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company +1 more
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pfizer CEO Buys $1 Million of Stock

This article first appeared on GuruFocus. Pfizer Inc. (PFE, Financials) The pharmaceutical giant earned a new vote of confidence from its top executive. Albert Bourla bought about $1 million worth of company stock. Bourla purchased 38,000 shares at $26.34 apiece, which increased his ownership …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company +1 more
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AppFolio director Maurice Duca sells $1.09m in shares By Investing.com

Maurice J. Duca, a director and 10% owner of AppFolio Inc. (NASDAQ:APPF), sold 5,442 shares of Class A Common Stock for over $1 million on August 11, 2026, as part of a pre-arranged trading plan. Despite the sale, InvestingPro analysis suggests AppFolio's stock is …

APPF main company
Sharemaestro market context Price above Trend Line 52 weeks -25.8% APPF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pfizer, Inc. Stock 12‑Month Price Target Cut to $28.28, Implies 7% Upside

The average 12-month price target for Pfizer, Inc. (PFE) stock has been reduced from $28.47 to $28.28 by 24 analysts, with forecasts ranging from $25 to $35.75. This updated target implies a potential upside of approximately 7% from the Aug. 12 closing price. The …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AppFolio principal accounting officer Don Rigler sells $29,380 in shares By Investing.com

Don Rigler, Principal Accounting Officer at AppFolio Inc. (NASDAQ:APPF), sold 150 shares of Class A Common Stock for $29,380 and disposed of 107 additional shares to cover tax withholding obligations. These transactions occurred on August 10, 2026, as per a pre-arranged plan. Rigler now …

APPF main company
Sharemaestro market context Price above Trend Line 52 weeks -25.8% APPF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

TechnipFMC (FTI) Is Down 6.6% After Major Buyback And Solid Q2 Results Has The Bull Case Changed?

TechnipFMC (FTI) reported strong Q2 2026 results with significant revenue and net income, alongside reaffirming full-year guidance and a quarterly dividend. The company also completed a substantial share buyback, retiring 17.82% of its shares for US$2.31 billion, which significantly alters its capital structure. Despite …

FTI main company
Sharemaestro market context Trend signal active 52 weeks +118.2% · Next-week setup positive 57.9% FTI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

5 Insightful Analyst Questions From Pfizer’s Q2 Earnings Call

5 Insightful Analyst Questions From Pfizer's Q2 Earnings Call Pfizer's second quarter results reflected stability in its core business despite ongoing challenges in COVID-related product demand. The company's performance was shaped by strong execution in its non-COVID portfolio, with management highlighting robust revenue contributions …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Oppfi CEO Todd Schwartz buys $422,988 in company stock

OppFi CEO Todd G. Schwartz recently purchased 60,000 shares of the company's Class A Common Stock for $422,988, increasing his indirect beneficial ownership through a trust. This purchase occurred as OPFI stock experienced a significant decline, yet InvestingPro analysis suggests the stock is undervalued …

OPFI main company
Sharemaestro market context Trend signal ended 52 weeks -26.8% OPFI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OppFi (OPFI) CEO Todd Schwartz adds 60,000 shares in open-market buy

OppFi Inc. CEO Todd G. Schwartz indirectly purchased 60,000 shares of Class A common stock on August 12, 2026, at a weighted average price of $7.0498 per share through the TGS Revocable Trust. This transaction increases the trust's holdings to 493,733 shares, with Schwartz …

OPFI main company
Sharemaestro market context Trend signal ended 52 weeks -26.8% OPFI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Insulet hires Pfizer alum Joan Campion to lead external comms

Insulet, a medical device company, has appointed Joan Campion, formerly of Pfizer, as its new VP of external communications for corporate affairs. This new role is part of a broader effort by Insulet to enhance its communications function under Chief Corporate Affairs Officer Cristal …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Listening to the Hemophilia Community: Pfizer Survey Reveals Unspoken Compromises

A Pfizer survey conducted with The Harris Poll found that many hemophilia patients and caregivers, while reporting satisfaction with current treatments, still experience significant burdens and make unspoken compromises in their daily lives. The survey, involving over 1,000 participants across four countries, highlighted challenges …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know

Halliburton, TechnipFMC, Antero Resources, APA Corporation, and Transocean Stocks Trade Up, What You Need To Know What Happened? A number of stocks jumped in the morning session after Brent crude failed to break below $80 and rebounded to the mid-$80s, as traders kept a …

T1EC34 main company FTI main company FTI main company
Sharemaestro market context Trend signal active 52 weeks +88.9% T1EC34 stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Will Pfizer's Non-COVID Portfolio Drive Its Next Phase of Growth?

Pfizer is shifting its growth strategy away from COVID-19 products, focusing instead on its non-COVID portfolio through new product launches, strategic acquisitions, and pipeline development in oncology and obesity. The company's recent Q2 2026 results showed significant operational growth in non-COVID revenues, leading to …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company +1 more
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Formation Bio taps Biogen, Pfizer alum to tackle R&D’s ‘boring middle’

Formation Bio has appointed Dr. Michael Ehlers, a former Biogen and Pfizer executive, as its new chief scientific officer and head of R&D. The company aims to leverage AI to optimize the often-overlooked "boring middle" of drug development, such as trial enrollment and site …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

YPF Sociedad Anónima Q2 Earnings Call Highlights

YPF Sociedad Anónima reported record Q2 2026 profitability with adjusted EBITDA reaching $2.8 billion, driven by higher international prices and expanding shale production. The company saw a significant increase in shale oil production and raised its full-year capital expenditure outlook, with most investment directed …

YPF main company
Sharemaestro market context Trend signal active 52 weeks +57.6% YPF stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pfizer (PFE) Agreed To A $44 Million Chantix Settlement

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Pfizer (NYSE:PFE) agreed to a US$44 million class action settlement related to its smoking cessation drug Chantix, addressing claims tied to product safety disclosures. …

PFE main company PFE main company PFIZ34 main company PFIZER main company PFE main company PFE main company +1 more
Sharemaestro market context Price above Trend Line 52 weeks +22.2% · Next-week setup positive 56.8% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pfizer (PFE) Agrees To $44 Million Class Action Settlement

Pfizer has agreed to a US$44 million class action settlement concerning its Chantix smoking cessation drug, addressing allegations of undisclosed carcinogenic nitrosamines. This settlement is considered small relative to Pfizer's substantial revenue, fitting within existing regulatory and product liability risk frameworks rather than introducing …

PFE main company
Sharemaestro market context Price above Trend Line 52 weeks +8.9% PFE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context